Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)

4 Jan 2018

Abstract excerpt

BACKGROUND: Triple Negative Breast Cancers (TNBCs) lack the appropriate targets for currently used breast cancer therapies, conferring an aggressive phenotype, more frequent relapse and poorer survival rates. The biological heterogeneity of TNBC complicates the clinical treatment further. We have explored and compared the biological pathways in TNBC and other subtypes of breast cancers, using an in silico...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to FOXO transcription factor regulation
Share to NF-κB Signaling Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29301506
DOI: 10.1186/s12885-017-3939-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)PMID 29301506Read ↗

Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis.Semantic proximity Read ↗

Exploring Molecular Pathways of Triple-Negative Breast CancerSemantic proximity Read ↗

Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics AnalysisSemantic proximity Read ↗

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancerSemantic proximity Read ↗

Development of a novel lipid metabolism-based signature to predict survival and immune response in triple negative breast cancerSemantic proximity Read ↗

Differentially Expressed Genes and Key Pathways in Triple Negative Breast Cancers: A Bioinformatics AnalysisSemantic proximity Read ↗

Genes and functions from breast cancer signaturesSemantic proximity Read ↗

Integrated analysis of expression profiling data identifies three genes in correlation with poor prognosis of triple-negative breast cancerSemantic proximity Read ↗

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity Read ↗

Triple Negative Breast Cancer: A Multi-Omics Network Discovery Strategy for Candidate Targets and Driving PathwaysSemantic proximity Read ↗

FBLN5 Is an Underlying Common Tumor Suppressor in Breast Cancer and Thyroid CancerSemantic proximity Read ↗

Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.